<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37005706</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1941-5923</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><PubDate><Year>2023</Year><Month>Apr</Month><Day>03</Day></PubDate></JournalIssue><Title>The American journal of case reports</Title><ISOAbbreviation>Am J Case Rep</ISOAbbreviation></Journal><ArticleTitle>A Case of Lupus Nephritis Preceded by Minimal Change Disease and Membranous Glomerulonephritis.</ArticleTitle><Pagination><StartPage>e938402</StartPage><MedlinePgn>e938402</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.12659/AJCR.938402</ELocationID><Abstract><AbstractText>BACKGROUND Lupus nephritis (LN) is the most common and serious complication of systemic lupus erythematosus (SLE). Minimal change disease (MCD) and primary membranous nephropathy (PMN) are the 2 most common causes of primary nephrotic syndrome. Our purpose in publishing this case report is to introduce an unusual clinical course and initial renal biopsy revealed MCD and then PMN in second renal biopsy. Subsequently, a third renal biopsy resulted in a final diagnosis of LN. To the best of our knowledge, this is the first such report. CASE REPORT The 31-year-old male patient was initially diagnosed with MCD after the first renal biopsy in 2004. He improved with initial management and had a complete remission for 9 years. After 9 years, the patient again presented with heavy proteinuria without systemic lupus erythematous finding and he was diagnosed with MN following the second renal biopsy. Seven years later, he again developed proteinuria alone with concurrent systemic symptoms of systemic lupus erythematosus, and a third biopsy was performed, leading to final diagnosis as LN. He was well managed with the methylprednisolone and cyclophosphamide (CTX) regimen, which improved renal function and spared the patient from continuous hemodialysis. CONCLUSIONS In rare case, MCD may represent an early phase of lupus nephritis, which may subsequently develop into severe lupus nephritis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Fengxia</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Division of Nephrology, First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, China (mainland).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Nan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China (mainland).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Munisamy Selvam</LastName><ForeName>Karthick Kumaran</ForeName><Initials>KK</Initials><AffiliationInfo><Affiliation>Division of Nephrology, First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, China (mainland).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Bohou</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China (mainland).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Qiong</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China (mainland).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wen</LastName><ForeName>Sichun</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of General Practice, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China (mainland).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Ruiquan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Urinary Surgery, First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, China (mainland).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Shuangxin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China (mainland).</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Case Rep</MedlineTA><NlmUniqueID>101489566</NlmUniqueID><ISSNLinking>1941-5923</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008181" MajorTopicYN="Y">Lupus Nephritis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015433" MajorTopicYN="Y">Glomerulonephritis, Membranous</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009402" MajorTopicYN="Y">Nephrosis, Lipoid</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011507" MajorTopicYN="N">Proteinuria</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of interest:</b> None declared</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>3</Day><Hour>1</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37005706</ArticleId><ArticleId IdType="pmc">PMC10083057</ArticleId><ArticleId IdType="doi">10.12659/AJCR.938402</ArticleId><ArticleId IdType="pii">938402</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Borchers AT, Leibushor N, Naguwa SM, et al. Lupus nephritis: A critical review. Autoimmun Rev. 2012;12(2):174&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">22982174</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei X, Wang Y, Tu L, et al. Acute kidney injury associated with minimal change disease in systemic lupus erythematosus: A case report. J Med Case Rep. 2014;8:422.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4301750</ArticleId><ArticleId IdType="pubmed">25495593</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YT, Chou HH, Chen FF, et al. A case of minimal-change nephrotic syndrome in pediatric lupus erythematosus: Just a coincidence? Lupus. 2006;15(4):244&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">16686266</ArticleId></ArticleIdList></Reference><Reference><Citation>Chauhan SK, Rai R, Singh VV, et al. Differential clearance mechanisms, neutrophil extracellular trap degradation and phagocytosis, are operative in systemic lupus erythematosus patients with distinct autoantibody specificities. Immunol Lett. 2015;168(2):254&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">26434792</ArticleId></ArticleIdList></Reference><Reference><Citation>Rekvig OP, Van der Vlag J. The pathogenesis and diagnosis of systemic lupus erythematosus: Still not resolved. Semin Immunopathol. 2014;36(3):301&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">24763531</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiou TT, Chau YY, Chen JB, et al. Rapamycin attenuates PLA2R activation-mediated podocyte apoptosis via the PI3K/AKT/mTOR pathway. Biomed Pharmacother. 2021;144:112349.</Citation><ArticleIdList><ArticleId IdType="pubmed">34700229</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiffer M, Schiffer LE, Gupta A, et al. Inhibitory smads and tgf-Beta signaling in glomerular cells. J Am Soc Nephrol. 2002;13(11):2657&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">12397035</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang MF, Cui Z, Zhang YM, et al. Clinical and prognostic significance of glomerular C1q deposits in primary MN. Clin Chim Acta. 2018;485:152&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">29969623</ArticleId></ArticleIdList></Reference><Reference><Citation>Walport MJ, Davies KA, Botto M. C1q and systemic lupus erythematosus. Immunobiology. 1998;199(2):265&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">9777411</ArticleId></ArticleIdList></Reference><Reference><Citation>Robson MG, Cook HT, Botto M, et al. Accelerated nephrotoxic nephritis is exacerbated in C1q-deficient mice. J Immunol. 2001;166(11):6820&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">11359841</ArticleId></ArticleIdList></Reference><Reference><Citation>Song YS, Min KW, Kim JH, et al. Differential diagnosis of lupus and primary membranous nephropathies by IgG subclass analysis. Clin J Am Soc Nephrol. 2012;7(12):1947&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3513749</ArticleId><ArticleId IdType="pubmed">23024158</ArticleId></ArticleIdList></Reference><Reference><Citation>Shearn MA, Hopper J, Jr, Biava CG. Membranous lupus nephropathy initially seen as idiopathic membranous nephropathy. Possible diagnostic value of tubular reticular structures. Arch Intern Med. 1980;140(11):1521&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">7436650</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck LH, Jr, Bonegio RG, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361(1):11&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2762083</ArticleId><ArticleId IdType="pubmed">19571279</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Vives E, Sol&#xe9; C, Molin&#xe9; T, et al. Antibodies to M-type phospholipase A2 receptor (PLA2R) in membranous lupus nephritis. Lupus. 2019;28(3):396&#x2013;405.</Citation><ArticleIdList><ArticleId IdType="pubmed">30760090</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>